Results

eNauka >  Results >  A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
Title: A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)
Authors: Ramalingam, S.; Goss, G.; Rosell, R.; Schmid-Bindert, G.; Zarić, Bojan  ; Andric, Z.; Bondarenko, I.; Komov, D.; Ceric, T.; Khuri, F.;
Issue Date: 2015
Publication: Annals of Oncology
ISSN: 0923-7534 Annals of Oncology Search Idenfier
Type: Article
Collation: vol. 26 br. 8 str. 1741-1748
DOI: 10.1093/annonc/mdv220
WoS-ID: 000359312100029
Scopus-ID: 2-s2.0-84941614654
URI: https://enauka.gov.rs/handle/123456789/483828
Metadata source: Migrirano iz RIS podataka
M-category: 
21aM21a

Altmetric
Dimensions

Find the DOI

Unpaywall

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.